Estimating seroprevalence of herpes simplex virus type 1 among different Middle East and North African male populations residing in Qatar

Journal of Medical Virology

Volumn 90, Issue 1, 2018, Pages 184-190

  Nasrallah, Gheyath K ^a   Dargham, Soha R ^b   Mohammed, Layla I ^a   Abu Raddad, Laith J ^b,c  

^a QATAR UNIVERSITY   (Qatar)

^b Department of Obstetrics Gynecology   (Qatar)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

herpes; herpes simplex virus type 1; Middle East and North Africa; prevalence; sexually transmitted infection

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGE; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EGYPTIAN; HUMAN; HUMAN ALPHAHERPESVIRUS 1; IRANIAN (CITIZEN); JORDANIAN; LEBANESE; MALE; MIDDLE AGED; MIDDLE EAST; NONHUMAN; NORTH AFRICA; PAKISTANI; PALESTINIAN; QATAR; QATARI; SEROPREVALENCE; SERUM; SUDANESE; SYRIAN; YEMENI; YOUNG ADULT; AFRICA; BLOOD; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL HERPES; HERPES SIMPLEX; IMMUNOLOGY; ISOLATION AND PURIFICATION; PREVALENCE; RISK FACTOR; SEROEPIDEMIOLOGY; SEXUALLY TRANSMITTED DISEASE; VIROLOGY;

ADULT; AFRICA, NORTHERN; ANTIBODIES, VIRAL; BLOOD DONORS; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST; PREVALENCE; QATAR; REAGENT KITS, DIAGNOSTIC; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEXUALLY TRANSMITTED DISEASES, VIRAL;

EID: 85034024356     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24916     Document Type: Article

References (43)

1. Smith J, Robinson N. Age-Specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002; 186:S3–S28.
2. Looker KJ, Magaret AS, May MT, et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in2012. PLoS ONE. 2015; 10:e0140765.
3. Gnann JW, Whitley RJ. Genital herpes. N Engl J Med. 2016; 375:666–674.
4. Gupta R, Warren T, Wald A. Genital herpes. Lancet. 2007; 370:2127–2137.
5. Xu F, Lee FK, Morrow RA, et al. Seroprevalence of herpes simplex virus type 1 in children in the United States. J Pediatr. 2007; 151:374–377.
6. Brady RC, Bernstein DI. Treatment of herpes simplex virus infections. Antiviral Res. 2004; 61:73–81.
7. Bernstein DI, Bellamy AR, Hook EW, 3rd, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis. 2013; 56:344–351.
8. Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of herpes simplex virus types 1 and 2-United States, 1999- 2010. J Infect Dis. 2014; 209:325–333.
9. Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol. 2007; 57:737–763. quiz 764–736.
10. Ryder N, Jin F, McNulty AM, Grulich AE, Donovan B. Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992- 2006. Sex Transm Infect. 2009; 85:416–419.
11. Lowhagen GB, Tunback P, Andersson K, Bergstrom T, Johannisson G. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infect. 2000; 76:179–182.
12. Nilsen A, Myrmel H. Changing trends in genital herpes simplex virus infection in Bergen, Norway. Acta Obstet Gynecol Scand. 2000; 79:693–696.
13. Samra Z, Scherf E, Dan M. Herpes simplex virus type 1 is the prevailing cause of genital herpes in the Tel Aviv area, Israel. Sex Transm Dis. 2003; 30:794–796.
14. Gilbert M, Li X, Petric M, et al. Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes. Can J Public Health. 2011; 102:225–229.
15. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis. 2003; 30:797–800.
16. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006; 296:964–973.
17. Kramer MA, Uitenbroek DG, Ujcic-Voortman JK, et al. Ethnic differences in HSV1 and HSV2 seroprevalence in Amsterdam, the Netherlands. Euro Surveill. 2008; 13:717–727.
18. Wutzler P, Doerr HW, Farber I, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol. 2000; 61:201–207.
19. Sauerbrei A, Schmitt S, Scheper T, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006. Euro Surveill. 2011; 16:20005.
20. Pebody RG, Andrews N, Brown D, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect. 2004; 80:185–191.
21. Aarnisalo J, Ilonen J, Vainionpaa R, Volanen I, Kaitosaari T, Simell O. Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the first eight years of life: a prospective study. Scand J Infect Dis. 2003; 35:750–753.
22. Vyse AJ, Gay NJ, Slomka MJ, et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect. 2000; 76:183–187.
23. Whitley RJ. Changing epidemiology of herpes simplex virus infections. Clin Infect Dis. 2013; 56:352–353.
24. Mark H, Gilbert L, Nanda J. Psychosocial well-being and quality of life among women newly diagnosed with genital herpes. J Obstet Gynecol Neonatal Nurs. 2009; 38:320–326.
25. Mindel A. Psychological and psychosexual implications of herpes simplex virus infections. Scand J Infect Dis Suppl. 1996; 100:27–32.
26. Ministry of Development Planning and Statistics. Qatar's Fourth National Human Development Report: Realising Qatar National Vision 2030, The Right to Development (Available at: http://hdr.undp.org/sites/default/files/qatar_nhdr4_english_15june2015.pdf). Ministry of Development Planning and Statistics; 2015.
27. AbuOdeh R, Al-Mawlawi N, Al-Qahtani AA, et al. Detection and genotyping of torque teno virus (TTV) in healthy blood donors and patients infected with HBV or HCV in Qatar. J Med Virol. 2015; 87:1184–1191.
28. AbuOdeh RO, Al-Absi E, Ali NH, et al. Detection and phylogenetic analysis of human pegivirus (GBV-C) among blood donors and patients infected with hepatitis B virus (HBV) in Qatar. J Med Virol. 2015; 87:2074–2081.
29. Al-Qahtani AA, Alabsi ES, AbuOdeh R, Thalib L, Nasrallah GK. Prevalence of anelloviruses (TTV, TTMDV, and TTMV) in healthy blood donors and in patients infected with HBV or HCV in Qatar. Virol J. 2016; 13:208.
30. Nasrallah GK, Al Absi ES, Ghandour R, et al. Seroprevalence of hepatitis E virus among blood donors in Qatar (2013–2016). Transfusion (Paris). 2017; 57:1801–1807.
31. Memish ZA, Almasri M, Chentoufi AA, et al. Seroprevalence of herpes simplex virus type 1 and type 2 and coinfection with HIV and syphilis: the first national seroprevalence survey in Saudi Arabia. Sex Transm Dis. 2015; 42:526–532.
32. Diagnostics F. HerpeSelect 1 ELISA IgG (English). 2011.
33. Petersen MR, Deddens JA. A comparison of two methods for estimating prevalence ratios. BMC Med Res Methodol. 2008; 8:9.
34. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and −sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl. 1990; 69:19–36.
35. Cowan FM, French RS, Mayaud P, et al. Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sex Transm Infect. 2003; 79:286–290.
36. Dolar N, Serdaroglu S, Yilmaz G, Ergin S. Seroprevalence of herpes simplex virus type 1 and type 2 in Turkey. J Eur Acad Dermatol Venereol. 2006; 20:1232–1236.
37. Ibrahim A, Kouwatli K, Obeid M. Frequency of herpes simplex virus in Syria based on type-specific serological assay. Saudi Med J. 2000; 21:355–360.
38. Ghazi HO, Telmesani AM, Mahomed MF. TORCH agents in pregnant Saudi women. Med Princ Pract. 2002; 11:180–182.
39. Nizami D. Serological evaluation of HSV-1 and HSV-2 infection In pregnancy. Turk J Med Sci. 2003; 34:97–101.
40. Hossain A. Herpes simplex virus type 1 (HSV-1) and varicellazoster virus (VZV) infections in Saudi Arabia. J Trop Pediatr. 1989; 35:171–174.
41. Ashley-Morrow R, Nollkamper J, Robinson NJ, Bishop N, Smith J. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect. 2004; 10:530–536.
42. Mark HD, Nanda JP, Roberts J, Rompalo A, Melendez JH, Zenilman J. Performance of focus ELISA tests for HSV-1 and HSV-2 antibodies among university students with no history of genital herpes. Sex Transm Dis. 2007; 34:681–685.
43. United Nations Department of Economic and Social Affairs. World Population Prospects, the2015 Revision. 2015.